Research and Development (R&D)

See the following -

The Impact (Or Lack Thereof) Of Mobile Computing On Life Science R&D

Alex Clark | Pistoia Alliance | August 29, 2012

The computing transformation being effected by mobile computing may not be one we fully appreciate while burying our heads and thumbs in the latest cool app or game. Yet this transformation is likely the most important since the introduction of the personal computer... It’s that the transformation marks a complete change to the underlying platform. Read More »

The Indian Connection To Red Hat's Growth Story

Shivani Shinde Nadhe | Business Standard | July 25, 2013

Last financial year, open source software provider Red Hat became the first Linux vendor to breach the $1-billion revenue mark, recording a revenue of $1.3 billion. This growth story has a strong India connect. Read More »

Thomson Reuters Tackles Open Access Datasets With Data Citation Index

Nancy K. Herther | Information Today, Inc. | October 29, 2012

This month, Thomson Reuters began a soft launch of its new Data Citation Index, which is intended as “a comprehensive view of scholarly research bringing research data into the same arena as the published literature it supports. Read More »

Top 10 FOSS Legal Developments of 2014

The year 2014 continued the trend of the increasing importance of legal issues for the FOSS community. Continuing the tradition of looking back over the top ten legal developments in FOSS, my selection of the top ten issues for 2014 is as follows...

Read More »

TransCelerate BioPharma Inc. Publishes Risk-Based Monitoring Recommendations For Central Monitoring And Technology Considerations

Press Release | TransCelerate BioPharma Inc. | September 17, 2014

TransCelerate BioPharma Inc. ("TransCelerate") announced today the publication of its two most recent manuscripts on risk-based site monitoring ("Risk-Based Monitoring" or "RBM"), developed jointly by its 19 member companies. Both manuscripts have been accepted and published through the Drug Information Association's Therapeutic Innovation & Regulatory Science journal...

Read More »

Why Chemotherapy That Costs $70,000 In The U.S. Costs $2,500 In India

Thomas Bollyky | The Atlantic | April 10, 2013

By rejecting patent applications, developing countries have kept down the costs of much-needed medications. Can they continue to do so without harming efforts to develop new drugs? Read More »

Why China Is Beating the U.S. at Innovation

Paul Davidson | USA Today | April 17, 2017

For decades, America lost factories and jobs to China but retained a coveted title: the world's leader in inventing and commercializing new products. Now, even that status has been eroded, and it's hurting the economy. While the United States is still at the top in total investment in research and development — spending $500 billion in 2015 —  a new Boston Consulting Group (BCG) study released Monday has made a startling finding: A couple of years ago, China quietly surpassed the U.S. in spending on the later stage of R&D that turns discoveries into commercial products. And at its current rate of spending, China will invest up to  twice as much as the U.S., or $658 billion, by 2018 on this critical late-stage research...

Read More »

Pistoia Alliance US Conference 2017

Event Details
Type: 
Conference
Date: 
October 10, 2017 - 9:00am - 9:00pm
Location: 
Hilton Boston Back Bay
40 Dalton St
Boston, MA 02115
United States

The Pistoia Alliance US Conference 2017 is a free one-day conference put on by the Pistoia Alliance. This year's theme is "Lab of the Future" and will focus on how advances in automation, connectivity, machine learning, augmented reality, quantum computing, and blockchain are affecting clinical outcomes data and research data and diminishing the boundaries between hospitals, research laboratories, clinics, and ambulatory care...

Read More »